336 related articles for article (PubMed ID: 30032033)
1. Filling the drug discovery gap: is high-content screening the missing link?
Dorval T; Chanrion B; Cattin ME; Stephan JP
Curr Opin Pharmacol; 2018 Oct; 42():40-45. PubMed ID: 30032033
[TBL] [Abstract][Full Text] [Related]
2. Screening out irrelevant cell-based models of disease.
Horvath P; Aulner N; Bickle M; Davies AM; Nery ED; Ebner D; Montoya MC; Östling P; Pietiäinen V; Price LS; Shorte SL; Turcatti G; von Schantz C; Carragher NO
Nat Rev Drug Discov; 2016 Nov; 15(11):751-769. PubMed ID: 27616293
[TBL] [Abstract][Full Text] [Related]
3. The development of high-content screening (HCS) technology and its importance to drug discovery.
Fraietta I; Gasparri F
Expert Opin Drug Discov; 2016; 11(5):501-14. PubMed ID: 26971542
[TBL] [Abstract][Full Text] [Related]
4. High throughput technologies in drug discovery.
Kundu B
Comb Chem High Throughput Screen; 2011 Dec; 14(10):829. PubMed ID: 21843140
[No Abstract] [Full Text] [Related]
5. Approaches for high-throughput pharmacokinetic screening of low-molecular-weight drug candidates.
Fontana S
Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):139-42. PubMed ID: 24329157
[TBL] [Abstract][Full Text] [Related]
6. Concise review: a high-content screening approach to stem cell research and drug discovery.
Xia X; Wong ST
Stem Cells; 2012 Sep; 30(9):1800-7. PubMed ID: 22821636
[TBL] [Abstract][Full Text] [Related]
7. Modern drug discovery technologies: opportunities and challenges in lead discovery.
Guido RV; Oliva G; Andricopulo AD
Comb Chem High Throughput Screen; 2011 Dec; 14(10):830-9. PubMed ID: 21843147
[TBL] [Abstract][Full Text] [Related]
8. Label-free screening assays: a strategy for finding better drug candidates.
Lunn CA
Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
[TBL] [Abstract][Full Text] [Related]
9. Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening?
Eglen RM; Randle DH
Assay Drug Dev Technol; 2015 Jun; 13(5):262-5. PubMed ID: 26121065
[TBL] [Abstract][Full Text] [Related]
10. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
Roy A; McDonald PR; Sittampalam S; Chaguturu R
Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
[TBL] [Abstract][Full Text] [Related]
11. Advances in microfluidics for drug discovery.
Lombardi D; Dittrich PS
Expert Opin Drug Discov; 2010 Nov; 5(11):1081-94. PubMed ID: 22827746
[TBL] [Abstract][Full Text] [Related]
12. A CRISP(e)R view on kidney organoids allows generation of an induced pluripotent stem cell-derived kidney model for drug discovery.
Boreström C; Jonebring A; Guo J; Palmgren H; Cederblad L; Forslöw A; Svensson A; Söderberg M; Reznichenko A; Nyström J; Patrakka J; Hicks R; Maresca M; Valastro B; Collén A
Kidney Int; 2018 Dec; 94(6):1099-1110. PubMed ID: 30072040
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening in drug design and development.
Sousa SF; Cerqueira NM; Fernandes PA; Ramos MJ
Comb Chem High Throughput Screen; 2010 Jun; 13(5):442-53. PubMed ID: 20236061
[TBL] [Abstract][Full Text] [Related]
14. The Emerging Role of Neuronal Organoid Models in Drug Discovery: Potential Applications and Hurdles to Implementation.
Struzyna LA; Watt ML
Mol Pharmacol; 2021 Apr; 99(4):256-265. PubMed ID: 33547249
[TBL] [Abstract][Full Text] [Related]
15. The latest advances in high content screening in microfluidic devices.
Liu W; Wang J; Qi H; Jiao Q; Wu L; Wang Y; Liang Q
Expert Opin Drug Discov; 2023 Jul; 18(7):781-795. PubMed ID: 37219918
[TBL] [Abstract][Full Text] [Related]
16. The beautiful cell: high-content screening in drug discovery.
Bickle M
Anal Bioanal Chem; 2010 Sep; 398(1):219-26. PubMed ID: 20577725
[TBL] [Abstract][Full Text] [Related]
17. Challenges and Opportunities in Enabling High-Throughput, Miniaturized High Content Screening.
Nickischer D; Elkin L; Cloutier N; O'Connell J; Banks M; Weston A
Methods Mol Biol; 2018; 1683():165-191. PubMed ID: 29082493
[TBL] [Abstract][Full Text] [Related]
18. Cell-Based Assay Design for High-Content Screening of Drug Candidates.
Nierode G; Kwon PS; Dordick JS; Kwon SJ
J Microbiol Biotechnol; 2016 Feb; 26(2):213-25. PubMed ID: 26428732
[TBL] [Abstract][Full Text] [Related]
19. High-throughput fluorescence imaging approaches for drug discovery using in vitro and in vivo three-dimensional models.
Martinez NJ; Titus SA; Wagner AK; Simeonov A
Expert Opin Drug Discov; 2015 Dec; 10(12):1347-61. PubMed ID: 26394277
[TBL] [Abstract][Full Text] [Related]
20. Label-free drug screening assay multiplexed with an orthogonal time-resolved fluorescence labeled assay.
Kiss L; Cselenyák A; Visegrády A
Anal Biochem; 2019 Feb; 566():126-132. PubMed ID: 30452893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
